Unapproved Drugs: Enforcement Actions
Links shared publicly online about this topic.
- 1,341total visits
Unapproved Drugs: Enforcement Actions
fda.gov —
View full resource at fda.gov
Tags: Pain Medication, Drug, MS-Contin
Most Recently Shared on March 3, 2010 at 7:00 pm By:
RT @FDA_Drug_Info: Follow-up letters sent to manufacturers of unapproved morphine sulfate IR 20 mg/mL products. http://bit.ly/UN_MS
Senators call for stronger measures against Medicare Part D abuse - Related Stories - ANA SmartBrief
smartbrief.com — “Following a Government Accountability Office report on prescription drug abuse among Medicare Part D beneficiaries, senators from both parties on Tuesday have urged the agency to enforce more action against those who commit provider-shopping. The subpanel's top Democrat and Republican have already …” View full resource at smartbrief.com
Most Recently Shared on October 10, 2011 at 8:35 pm By:
RNchat Nursing and Health Social Media
RT @NurseEvette: #Senators call for stronger measures against #Medicare Part D abuse http://t.co/jsUngWNl #RNChat #MDChat
Unapproved Prescription Cough, Cold, and Allergy Drug Products
chestjournal.chestpubs.org — “Ostroff, Craig; Lee, Charles E.; McMeekin, Judith” View full resource at chestjournal.chestpubs.org
Most Recently Shared on August 17, 2011 at 1:57 am By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
The FDA recently took action against unapproved prescription oral cough, cold, and allergy drug products http://t.co/IBFgRpv
FDA To Make Enforcement And Compliance Activities Accessible Online
medicalnewstoday.com — “The U.S. Food and Drug Administration today announced that it is disclosing more information about inspections and court actions, and now has a web portal on its enforcement activities as part of” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 5:05 pm By:
MNT Drug Approvals Health News
FDA To Make Enforcement And Compliance Activities Accessible Online http://mnt.to/3Wqr #regulatory
NMQF President Applauds FDA Plan To Remove Over 500 Unapproved Drugs From Market - QualityPoint Technologies
qualitypointtech.net — “Gary Puckrein, President and CEO of the National Minority Quality Forum (The Forum), recently applauded the Food and Drug Administration's (FDA) actions taken to remove certain unapproved prescription oral cough, cold, and allergy medicines from the United States market place.” View full resource at qualitypointtech.net
Most Recently Shared on March 20, 2011 at 4:35 pm By:
NMQF President Applauds FDA Plan To Remove Over 500 Unapproved Drugs From Market: Gary Puckrein, President and CEO... http://bit.ly/hRriyb
FDA Prompts Removal of Unapproved Drugs From Market - Drugs.com MedNews
drugs.com — “Class action is part of FDA s Unapproved Drugs Initiative SILVER SPRING, Md., March 2, 2011 PRNewswire-USNewswire The U.S. Food and Drug Administration today to” View full resource at drugs.com
Most Recently Shared on March 2, 2011 at 6:05 pm By:
Drugs and Devices OW OW Health
FDA Prompts Removal of Unapproved Drugs From Market: Â Class action is part of FDA's Unapproved Drugs Init... http://bit.ly/ftmcKX #drug
FDA prompts removal of unapproved drugs from market
fda.gov — “The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, or market certain unapproved prescription oral cough, cold, and allergy products.” View full resource at fda.gov
Most Recently Shared on March 2, 2011 at 3:43 pm By:
Trish D'Antonio Health Professional
FDA prompts removal of unapproved drugs from market http://t.co/YxRktQ3
Medical News: FDA Targets Drugs Sold as Supplements - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “Having issued nearly 300 consumer alerts, warning letters, and other enforcement actions targeting dietary supplements that actually contain drug compounds, the FDA is mounting a new effort to disco” View full resource at medpagetoday.com
Most Recently Shared on December 16, 2010 at 12:41 am By:
FDA Targets Drugs Sold as Supplements http://bit.ly/hZ1oV8
Medical News: FDA Targets Drugs Sold as Supplements - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “Having issued nearly 300 consumer alerts, warning letters, and other enforcement actions targeting dietary supplements that actually contain drug compounds, the FDA is mounting a new effort to disco” View full resource at medpagetoday.com
Most Recently Shared on December 15, 2010 at 11:53 pm By:
FDA Targets Drugs Sold as Supplements http://bit.ly/fJ4QDt
AAHSA applauds senator's hold on DEA nominee - McKnight's Long Term Care News
mcknights.com — “A major long-term care association Monday praised the decision by Sen. Herb Kohl (D-WI) to place a hold on the nomination of Michelle Leonhart to head the U.S. Drug Enforcement Agency. He took such action because he believes the DEA needs to change its policy regarding the delivery of painkillers by nurses in long-term care settings.” View full resource at mcknights.com
Most Recently Shared on December 7, 2010 at 3:46 pm By:
McKnight's LTC News Health News and Medical Publisher
AAHSA applauds senator's hold on DEA nominee http://bit.ly/hdTLqY #healthcare
--'Legal Highs--™ K2 and Spice Will Be Banned
webmd.com — “The U.S. Drug Enforcement Administration is invoking its emergency powers to declare K2, Spice, and other” View full resource at webmd.com
Most Recently Shared on November 29, 2010 at 4:34 pm By:
‘Legal Highs’ #K2 and #Spice Will Be Banned: DEA Has Declared the Drugs Illegal; Action Takes Effect in 30 Days http://bit.ly/guouZV
FDA Cracks Down on Unapproved Chelation Products
thenewamerican.com — “The Food and Drug Administration (FDA), in its role as enforcer of politically-acceptable medical practice, has just out warning letters regarding a medical treatment known as chelation. By Michael Tennant” View full resource at thenewamerican.com
Most Recently Shared on October 18, 2010 at 4:05 am By:
Sandra Cottingham Health Business and Parenting Supporter
FDA Cracks Down on Unapproved Chelation Products http://bit.ly/bthFKE
NMQF CEO Applauds FDA For Removing Unapproved Colchicine From Market - QualityPoint Technologies
qualitypointtech.net — “Gary Puckrein, President and CEO of the National Minority Quality Forum (The Forum), recently spoke out in support of the Food and Drug Administration's (FDA) actions taken to remove unapproved colchicine products from the marketplace.” View full resource at qualitypointtech.net
Most Recently Shared on October 15, 2010 at 1:25 pm By:
NMQF CEO Applauds FDA For Removing Unapproved Colchicine From Market: Gary Puckrein, President and CEO of the Nati... http://bit.ly/9MPeK4
Government takes action against Montana drug manufacturer
fda.gov — “The U.S. Food and Drug Administration today announced that Toby McAdam and Greta Armstrong, doing business as Risingsun Health and The Center for Complimentary and Alternative Health of Livingston, Montana, have signed a consent decree that prohibits them from manufacturing and selling unapproved new drugs and adulterated or misbranded dietary supplements in violation of the law.” View full resource at fda.gov
Most Recently Shared on October 14, 2010 at 3:01 pm By:
eyeonfda Pharma and Health Lawyer
Government takes action against Montana drug manufacturer (complementary health) 4 selling unapproved drugs - http://ow.ly/2TujS
FDA Orders Halt to Marketing of Unapproved Single-ingredient Oral Colchicine - Drugs.com MedNews
drugs.com — “Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) The U.S. Food and Drug Administration today took action agai” View full resource at drugs.com
Most Recently Shared on October 1, 2010 at 12:18 pm By:
Drugs and Devices OW OW Health
FDA Orders Halt to Marketing of Unapproved Single-ingredient Oral Colchicine: Drug commonly used to prevent g... http://bit.ly/aGD2VH #drug
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
fda.gov — “The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF).” View full resource at fda.gov
Most Recently Shared on September 30, 2010 at 6:55 pm By:
eyeonfda Pharma and Health Lawyer
RT @FDA_Drug_Info: FDA orders halt to marketing of unapproved single-ingredient oral colchicine. http://bit.ly/oralcolchicine
Advertisement
